First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Published Online: 2018-05-29
Journal: Journal of Translational MedicineLoading...
Authors: Andrew E. Sloan•Andrew J. Brenner•Anthony E. Maida•Arnold B. Etame•Charles S. Cobbs•Christopher Duma•Clement P. Pillainayagam•Daniela A. Bota•David D. Tran•David E. Avigan•David Mathieu•David Piccioni•David S. Baskin•Dietmar Krex•Edward J. Dropcho•Fabio M. Iwamoto•Francois J. Geoffroy•Gabriele Schackert•Hans-Jorg Meisel•Heinrich Elinzano•Jai Grewal•Jana Portnow•Jason A. Heth•Jian L. Campian•John E. Trusheim•John L. Villano•Jose Lutzky•Julian Wu•Karen L. Fink•Kevin A. Walter•Kevin O. Lillehei•Kevin Petrecca•Keyoumars Ashkan•Linda M. Liau•Lyndon J. Kim•Lynne P. Taylor•Manfred Westphal•Marnix L. Bosch•Matthew G. Ewend•Michael Pearlman•Michael Salacz•Michael Schulder•Michel Lacroix•Pamela Z. New•Paul Duic•Paul Mulholland•Raphael P. Davis•Reid C. Thompson•Rekha Chaudhary•Richard M. Green•Robert Aiken•Robert M. Prins•Samuel A. Goldlust•Santosh Kesari•Sarah Taylor•Scott Lindhorst•Simon Khagi•Stacy D. D’Andre•Steven A. Toms•Steven Brem•Steven R. Abram•Sven-Axel May•Timothy F. Cloughesy•Timothy J. Pluard•Tobias Walbert•Tom Mikkelsen•Victor Tse•William G. Loudon•Yaron A. Moshel
